Diogo Estêvão

Dr. Diogo Estêvão

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
DEDiogo Estêvão
Diogo Estêvão
NCNatália Rios Costa
Natália Rios Costa
Rui M. Gil da CostaRui M. Gil da Costa
Rui M. Gil da Costa
Rui MedeirosRui Medeiros
Rui Medeiros

5 June 2023 in Cellular Oncology
Verified
Journal Article
Open access
PDF file
DEDiogo Estêvão
Diogo Estêvão
MCMiguel da Cruz-Ribeiro
Miguel da Cruz-Ribeiro
ACAna Patrícia Cardoso
Ana Patrícia Cardoso
ACAngela Costa
Angela Costa
Maria  OliveiraMaria Oliveira
Maria Oliveira
TCTania Cruz
Tania Cruz
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second deadliest malignancy worldwide. Current dietary habits are associated with increased levels of iron and heme, both of which increase the risk of developing CRC. The harmful effects of iron overload are related to the induction of iron-mediated pro-tumorigenic pathways, including carcinogenesis and hyperproliferation. On the other hand, iron deficiency may also promote CRC development and progression by contributing to genome instability, therapy resistance, and diminished immune responses. In addition to the relevance of systemic iron levels, iron-regulatory mechanisms in the tumor microenvironment are also believed to play a significant role in CRC and to influence disease outcome. Furthermore, CRC cells are more prone to escape iron-dependent cell death (ferroptosis) than non-malignant cells due to the constitutive activation of antioxidant genes expression. There is wide evidence that inhibition of ferroptosis may contribute to the resistance of CRC to established chemotherapeutic regimens. As such, ferroptosis inducers represent promising therapeutic drugs for CRC. Conclusions and perspectives: This review addresses the complex role of iron in CRC, particularly in what concerns the consequences of iron excess or deprivation in tumor development and progression. We also dissect the regulation of cellular iron metabolism in the CRC microenvironment and emphasize the role of hypoxia and of oxidative stress (e.g. ferroptosis) in CRC. Finally, we underline some iron-related players as potential therapeutic targets against CRC malignancy.

12 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ÂMÂngela Magalhães
Ângela Magalhães
TCTania Cruz
Tania Cruz
ACAngela Costa
Angela Costa
DEDiogo Estêvão
Diogo Estêvão
ERElisabete Rios
Elisabete Rios
ACAna Patrícia Cardoso
Ana Patrícia Cardoso
More than a physical structure providing support to tissues, the extracellular matrix (ECM) is a complex and dynamic network of macromolecules that modulates the behavior of both cancer cells and associated stromal cells of the tumor microenvironment (TME). Over the last few years, several efforts have been made to develop new models that accurately mimic the interconnections within the TME and specifically the biomechanical and biomolecular complexity of the tumor ECM. Particularly in colorectal cancer, the ECM is highly remodeled and disorganized and constitutes a key component that affects cancer hallmarks, such as cell differentiation, proliferation, angiogenesis, invasion and metastasis. Therefore, several scaffolds produced from natural and/or synthetic polymers and ceramics have been used in 3D biomimetic strategies for colorectal cancer research. Nevertheless, decellularized ECM from colorectal tumors is a unique model that offers the maintenance of native ECM architecture and molecular composition. This review will focus on innovative and advanced 3D-based models of decellularized ECM as high-throughput strategies in colorectal cancer research that potentially fill some of the gaps between in vitro 2D and in vivo models. Our aim is to highlight the need for strategies that accurately mimic the TME for precision medicine and for studying the pathophysiology of the disease.

28 January 2020 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
VMVerónica F. Mestre
Verónica F. Mestre
BFBeatriz Fonseca
Beatriz Fonseca
DEDiogo Estêvão
Diogo Estêvão
FCFátima Casaca
Fátima Casaca
SSSandra Silva
Sandra Silva
Rui M. Gil da CostaRui M. Gil da Costa
Rui M. Gil da Costa

17 February 2025 in Scientific Data
Verified
Journal Article
Open access
PDF file
EBEva Blondeel
Eva Blondeel
APArne Peirsman
Arne Peirsman
SVStephanie Vermeulen
Stephanie Vermeulen
Filippo PiccininiFilippo Piccinini
Filippo Piccinini
FVFelix De Vuyst
Felix De Vuyst
OWOlivier De Wever
Olivier De Wever
The application of three-dimensional (3D) cell cultures such as spheroids and organoids is growing in popularity both in academia and industry. However, morphology of the 3D architecture remains remarkably understudied. Here, we introduce an open-access Spheroid Light Microscopy Image Atlas (SLiMIA) that can serve as a training set for morphology studies of 3D cell cultures. We provide images with a variety of metadata: 9 microscopes, 47 cell lines, 8 culture media, 4 spheroid formation methods and multiple cell seeding densities; totalling approximately 8,000 images of spheroids. This comprehensive dataset can guide spheroid researchers and promote economizing of resources by advancing 3D cell culture optimization, standardization and implementation by the community at large. Considering the exponentially growing interest in spheroid morphometrical analyses and the emerging technological possibilities to do so, this atlas can be applied to train and develop image segmentation models to deepen our understanding of 3D spheroid morphometry in biomedical research.

8 April 2025 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
EBEva Blondeel
Eva Blondeel
SESam Ernst
Sam Ernst
FVFelix De Vuyst
Felix De Vuyst
ÁDÁkos Diósdi
Ákos Diósdi
CPCláudio Pinheiro
Cláudio Pinheiro
OWOlivier De Wever
Olivier De Wever